Phibro, an animal health and mineral nutrition company, is set to create 150 jobs in Sligo, Ireland over the next five years.
Phibro is headquartered in the US and it plans to establish a biotech facility producing a range of animal health vaccines at the IDA Business Park in Finisklin, Sligo, Ireland. Initially set to focus on producing Phibro’s vaccines for treatment of range of poultry diseases for global sales, Phibro’s Ireland facility is the first facility in Europe and the company eventually plans to expand production for livestock and aquaculture.
Phibro employs more than 1400 people globally operating in 65 countries, Phibro primarily develops, manufactures and markets a broad line of animal health and nutrition products for poultry, pigs, cattle, dairy and aquaculture. Headquartered in Teaneck, New Jersey, US, Phibro was founded in 1846 and has had annual sales of $764 million last year.
According to Jack Bendheim, Phibro’s chairman, president and chief executive:
“The creation of Phibro Ireland marks an important milestone in our development as a leading global player in the animal health biological market. The winning combination of Phibro’s expertise in the development and manufacture of biological products, the driven and experienced workforce available in the Sligo area, and the strong support of the IDA makes us very excited about the potential of the Sligo facility.”
Headquartered in the US, Phibro Animal health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. Employing around 1400 people globally, Phibro Animal Health Corporation operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro was founded in 1846.